Novartis AG - 예탁증서(보통주)
DE ˙ DB ˙ US66987V1098
€121.00 0.00 (0.00%)
2026-06-04
주가
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionTrust Co
Latest Disclosed Ownership459 shares
Latest Disclosed Value $ 70,112
Trust Co ownership in NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 13, 2026 - Trust Co filed a 13F-HR form disclosing ownership of 459 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $58,982 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 459 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $55,539 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 459 0 0.00 70 11.11 0.0066
2026-01-15 2025-12-31 13F NOVARTIS AG SPONSORED ADR ADR 66987V109 459 159 53.00 63 65.79 0.0059
2025-10-06 2025-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 300 0 0.00 38 5.56 0.0039
2025-07-07 2025-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 300 0 0.00 36 9.09 0.0041
2025-04-08 2025-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 300 0 0.00 33 13.79 0.0040
2025-01-14 2024-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 300 100 50.00 29 26.09 0.0033
2024-10-03 2024-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 23 9.52 0.0028
2024-07-15 2024-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 21 10.53 0.0027
2024-04-11 2024-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 19 -5.00 0.0025
2024-01-10 2023-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 20 0.00 0.0026
2023-12-04 2023-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 20 0.00 0.0033
2023-07-10 2023-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 20 11.11 0.0030
2023-04-07 2023-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 18 0.00 0.0028
2023-01-09 2022-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 0 -100.00 0.0029
2022-10-11 2022-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 15 -11.76 0.0033
2022-07-06 2022-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 17 -5.56 0.0037
2022-04-08 2022-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 18 5.88 0.0035
2022-01-14 2021-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 17 6.25 0.0040
2021-10-20 2021-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 16 -11.11 0.0041
2021-07-14 2021-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 18 5.88 0.0126
2021-04-08 2021-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 -32 -13.79 17 -22.73 0.0123
2021-01-12 2020-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 232 32 16.00 22 29.41 0.0174
2020-10-06 2020-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 17 0.00 0.0143
2020-07-17 2020-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 17 6.25 0.0162
2020-04-07 2020-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 16 -15.79 0.0176
2020-01-07 2019-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 19 11.76 0.0167
2019-10-09 2019-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 17 -5.56 0.0161
2019-07-08 2019-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 18 -5.26 0.0166
2019-04-08 2019-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 19 11.76 0.0111
2019-01-22 2018-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 17 0.00 0.0095
2018-10-09 2018-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 17 13.33 0.0077
2018-07-10 2018-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 15 -6.25 0.0069
2018-04-09 2018-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 0 0.00 16 -5.88 0.0059
2018-03-09 2017-12-31 13F/A-1 Novartis AG-ADR SPONSORED ADR 66987V109 200 -84 -29.58 17 -29.17 0.0070
2018-01-11 2017-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 200 -84 17
2017-10-12 2017-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 284 0 0.00 24 0.00 0.0132
2017-07-07 2017-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 284 -307 -51.95 24 -45.45 0.0111
2017-04-06 2017-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 591 -243 -29.14 44 -27.87 0.0200
2017-01-12 2016-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 834 -9,474 -91.91 61 -92.51 0.0310
2016-10-19 2016-09-30 13F Novartis AG-ADR NOVARTIS A G SPONSORED ADR 66987V109 10,308 -30,139 -74.51 814 -75.61 0.3570
2016-07-08 2016-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 40,447 -223 -0.55 3,337 13.27 1.2748
2016-04-08 2016-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 40,670 3,550 9.56 2,946 -7.74 1.3477
2016-01-26 2015-12-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 37,120 6,108 19.70 3,194 12.00 1.4786
2015-10-13 2015-09-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 31,012 14,466 87.43 2,851 75.23 1.6179
2015-07-10 2015-06-30 13F Novartis AG-ADR SPONSORED ADR 66987V109 16,546 -3,945 -19.25 1,627 -19.50 1.0165
2015-05-07 2015-03-31 13F Novartis AG-ADR SPONSORED ADR 66987V109 20,491 20,491 2,021 1.2771
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.